HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2- (2- methoxybenzyl)- 3- (1,10- phenanthrolin- 2- yl)isoxazolidin- 5- yl)methanol

structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Isoxazoles: 155
      - 2-(2-methoxybenzyl)-3-(1,10-phenanthrolin-2-yl)isoxazolidin-5-yl)methanol: 1

Experts

1.	Abbadessa, Antonio: 1 article (01/2018)
2.	Amata, Emanuele: 1 article (01/2018)
3.	Castilho, Rogerio M: 1 article (01/2018)
4.	Floresta, Giuseppe: 1 article (01/2018)
5.	Mineo, Placido G: 1 article (01/2018)
6.	Monciino, Giulia: 1 article (01/2018)
7.	Nicosia, Angelo: 1 article (01/2018)
8.	Pistarà, Venerando: 1 article (01/2018)
9.	Rescifina, Antonio: 1 article (01/2018)
10.	Varrica, Maria G: 1 article (01/2018)

Related Diseases

1.	Carcinoma (Carcinomatosis) 01/01/2018 - "((3RS,5SR)- and ((3RS,5RS)-2-(2-methoxybenzyl)-3-(1,10-phenanthrolin-2-yl)isoxazolidin-5-yl)methanol have been synthesized, according to 1,3-dipolar cycloaddition methodology, as DNA intercalating agents and evaluated for their anticancer activity against human cervical carcinoma HeLa and head and neck squamous cells carcinoma cell lines. "

Related Drugs and Biologics

1.	Intercalating Agents
2.	DNA (Deoxyribonucleic Acid)